Cargando…

Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms

OBJECTIVES: The emergence of new variants of SARS-CoV-2 is continuously posing pressure to the epidemic prevention and control in China. The Omicron variant of SARS-CoV-2 having stronger infectivity, immune escape ability, and capability causing repetitive infection spread to many countries and regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peiyan, Cai, Zhao, He, Zhiguang, Chen, Peifen, Wu, Weibo, Lin, Yuanlong, Feng, Shiyan, Peng, Ling, Li, Jianming, Yuan, Jing, Yang, Liang, Wang, Fuxiang, Liu, Yingxia, Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751512/
https://www.ncbi.nlm.nih.gov/pubmed/36522750
http://dx.doi.org/10.1186/s40001-022-00927-1
_version_ 1784850488776196096
author Zhang, Peiyan
Cai, Zhao
He, Zhiguang
Chen, Peifen
Wu, Weibo
Lin, Yuanlong
Feng, Shiyan
Peng, Ling
Li, Jianming
Yuan, Jing
Yang, Liang
Wang, Fuxiang
Liu, Yingxia
Lu, Hongzhou
author_facet Zhang, Peiyan
Cai, Zhao
He, Zhiguang
Chen, Peifen
Wu, Weibo
Lin, Yuanlong
Feng, Shiyan
Peng, Ling
Li, Jianming
Yuan, Jing
Yang, Liang
Wang, Fuxiang
Liu, Yingxia
Lu, Hongzhou
author_sort Zhang, Peiyan
collection PubMed
description OBJECTIVES: The emergence of new variants of SARS-CoV-2 is continuously posing pressure to the epidemic prevention and control in China. The Omicron variant of SARS-CoV-2 having stronger infectivity, immune escape ability, and capability causing repetitive infection spread to many countries and regions all over the world including South Africa, United States and United Kingdom etc., in a short time. The outbreaks of Omicron variant also occurred in China. The aim of this study is to understand the epidemiological characteristics of Omicron variant infection in Shenzhen and to provide scientific basis for effective disease control and prevention. METHODS: The clinical data of 394 imported COVID-19 cases infected with Omicron variant from 16 December 2021 to 24 March 2022 admitted to the Third People’s hospital of Shenzhen were collected and analyzed retrospectively. Nucleic acid of SARS-CoV-2 of nasopharyngeal swabs and blood samples was detected using 2019-nCoV nucleic acid detection kit. Differences in Ct values of N gene were compared between mild group and moderate group. The specific IgG antibody was detected using 2019-nCoV IgG antibody detection kit. Statistical analysis was done using SPSS software and graphpad prism. RESULTS: Patients were categorized into mild group and moderate group according to disease severity. The data on the general conditions, underlying diseases, COVID-19 vaccination and IgG antibody, viral load, laboratory examination results, and duration of hospitalization, etc., were compared among disease groups. Mild gorup had higher IgG level and shorter nucleic acid conversion time. Patients with underlying diseases have 4.6 times higher probability to progress to moderate infection. CONCLUSION: In terms of epidemic prevention, immunization coverage should be strengthened in the population with underlying diseases. In medical institutions, more attention needs to be paid to such vulnerable population and prevent further deterioration of the disease.
format Online
Article
Text
id pubmed-9751512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97515122022-12-15 Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms Zhang, Peiyan Cai, Zhao He, Zhiguang Chen, Peifen Wu, Weibo Lin, Yuanlong Feng, Shiyan Peng, Ling Li, Jianming Yuan, Jing Yang, Liang Wang, Fuxiang Liu, Yingxia Lu, Hongzhou Eur J Med Res Research OBJECTIVES: The emergence of new variants of SARS-CoV-2 is continuously posing pressure to the epidemic prevention and control in China. The Omicron variant of SARS-CoV-2 having stronger infectivity, immune escape ability, and capability causing repetitive infection spread to many countries and regions all over the world including South Africa, United States and United Kingdom etc., in a short time. The outbreaks of Omicron variant also occurred in China. The aim of this study is to understand the epidemiological characteristics of Omicron variant infection in Shenzhen and to provide scientific basis for effective disease control and prevention. METHODS: The clinical data of 394 imported COVID-19 cases infected with Omicron variant from 16 December 2021 to 24 March 2022 admitted to the Third People’s hospital of Shenzhen were collected and analyzed retrospectively. Nucleic acid of SARS-CoV-2 of nasopharyngeal swabs and blood samples was detected using 2019-nCoV nucleic acid detection kit. Differences in Ct values of N gene were compared between mild group and moderate group. The specific IgG antibody was detected using 2019-nCoV IgG antibody detection kit. Statistical analysis was done using SPSS software and graphpad prism. RESULTS: Patients were categorized into mild group and moderate group according to disease severity. The data on the general conditions, underlying diseases, COVID-19 vaccination and IgG antibody, viral load, laboratory examination results, and duration of hospitalization, etc., were compared among disease groups. Mild gorup had higher IgG level and shorter nucleic acid conversion time. Patients with underlying diseases have 4.6 times higher probability to progress to moderate infection. CONCLUSION: In terms of epidemic prevention, immunization coverage should be strengthened in the population with underlying diseases. In medical institutions, more attention needs to be paid to such vulnerable population and prevent further deterioration of the disease. BioMed Central 2022-12-15 /pmc/articles/PMC9751512/ /pubmed/36522750 http://dx.doi.org/10.1186/s40001-022-00927-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Peiyan
Cai, Zhao
He, Zhiguang
Chen, Peifen
Wu, Weibo
Lin, Yuanlong
Feng, Shiyan
Peng, Ling
Li, Jianming
Yuan, Jing
Yang, Liang
Wang, Fuxiang
Liu, Yingxia
Lu, Hongzhou
Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title_full Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title_fullStr Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title_full_unstemmed Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title_short Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
title_sort analysis of 394 covid-19 cases infected with omicron variant in shenzhen: impact of underlying diseases to patient’s symptoms
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751512/
https://www.ncbi.nlm.nih.gov/pubmed/36522750
http://dx.doi.org/10.1186/s40001-022-00927-1
work_keys_str_mv AT zhangpeiyan analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT caizhao analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT hezhiguang analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT chenpeifen analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT wuweibo analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT linyuanlong analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT fengshiyan analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT pengling analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT lijianming analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT yuanjing analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT yangliang analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT wangfuxiang analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT liuyingxia analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms
AT luhongzhou analysisof394covid19casesinfectedwithomicronvariantinshenzhenimpactofunderlyingdiseasestopatientssymptoms